B

Bangkok Dusit Medical Services PCL
SET:BDMS

Watchlist Manager
Bangkok Dusit Medical Services PCL
SET:BDMS
Watchlist
Price: 24.5 THB -0.41% Market Closed
Market Cap: 389.4B THB
Have any thoughts about
Bangkok Dusit Medical Services PCL?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

106.8B
+2%
Revenue
Growth Rates:
1 Year
+9%
3 Years
+51%
5 Years
+31%
7 Years
+51%
10 Years
+97%
20.3B
+2%
Operating Income
Growth Rates:
1 Year
+13%
3 Years
+117%
5 Years
+80%
7 Years
+100%
10 Years
+136%
15.6B
+2%
Net Income
Growth Rates:
1 Year
+15%
3 Years
+103%
5 Years
+7%
7 Years
+54%
10 Years
+125%

Earnings Waterfall
Bangkok Dusit Medical Services PCL

Revenue
106.8B THB
Cost of Revenue
-67.4B THB
Gross Profit
39.4B THB
Operating Expenses
-19.1B THB
Operating Income
20.3B THB
Other Expenses
-4.7B THB
Net Income
15.6B THB

Income Statement
Bangkok Dusit Medical Services PCL

Rotate your device to view
Income Statement
Currency: THB
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
54 259
N/A
56 054
+3%
57 701
+3%
59 332
+3%
61 121
+3%
62 834
+3%
64 420
+3%
65 257
+1%
67 215
+3%
67 985
+1%
68 042
+0%
69 471
+2%
70 754
+2%
71 933
+2%
74 343
+3%
75 665
+2%
76 504
+1%
77 373
+1%
78 579
+2%
79 743
+1%
81 243
+2%
82 723
+2%
81 918
-1%
76 291
-7%
71 385
-6%
68 074
-5%
64 361
-5%
67 738
+5%
70 683
+4%
74 451
+5%
81 410
+9%
86 019
+6%
90 054
+5%
91 934
+2%
92 958
+1%
95 267
+2%
97 983
+3%
100 853
+3%
103 452
+3%
105 074
+2%
106 808
+2%
Gross Profit
Cost of Revenue
(35 300)
(36 473)
(37 686)
(38 861)
(40 127)
(41 151)
(42 270)
(43 039)
(44 506)
(45 277)
(45 601)
(46 546)
(47 204)
(47 975)
(48 935)
(49 589)
(49 995)
(50 502)
(51 813)
(52 671)
(53 642)
(54 277)
(53 821)
(50 659)
(47 867)
(46 371)
(44 473)
(46 382)
(48 337)
(49 462)
(52 862)
(55 248)
(57 102)
(58 329)
(59 000)
(60 285)
(61 775)
(63 412)
(65 026)
(66 258)
(67 423)
Gross Profit
18 958
N/A
19 580
+3%
20 016
+2%
20 472
+2%
20 994
+3%
21 683
+3%
22 149
+2%
22 217
+0%
22 709
+2%
22 708
0%
22 441
-1%
22 924
+2%
23 549
+3%
23 957
+2%
25 409
+6%
26 078
+3%
26 510
+2%
26 871
+1%
26 766
0%
27 072
+1%
27 601
+2%
28 446
+3%
28 097
-1%
25 631
-9%
23 518
-8%
21 703
-8%
19 888
-8%
21 356
+7%
22 346
+5%
24 989
+12%
28 548
+14%
30 771
+8%
32 952
+7%
33 604
+2%
33 957
+1%
34 981
+3%
36 208
+4%
37 440
+3%
38 426
+3%
38 816
+1%
39 386
+1%
Operating Income
Operating Expenses
(10 358)
(10 620)
(10 837)
(11 252)
(11 685)
(11 850)
(12 211)
(12 198)
(12 396)
(13 644)
(12 845)
(13 211)
(13 406)
(14 488)
(14 006)
(14 238)
(14 326)
(15 998)
(15 623)
(15 963)
(16 348)
(16 395)
(15 836)
(14 862)
(13 816)
(13 178)
(10 184)
(10 548)
(12 978)
(13 766)
(14 587)
(15 274)
(16 463)
(16 621)
(17 099)
(17 693)
(18 305)
(18 548)
(18 790)
(18 997)
(19 103)
Selling, General & Administrative
(11 015)
(10 563)
(11 563)
(12 009)
(12 373)
(11 816)
(12 975)
(13 009)
(13 248)
(12 704)
(13 805)
(14 148)
(14 356)
(13 503)
(14 828)
(15 051)
(15 146)
(15 024)
(16 576)
(16 932)
(17 360)
(16 431)
(16 925)
(15 918)
(14 868)
(13 026)
(13 586)
(13 994)
(14 236)
(14 064)
(15 770)
(16 431)
(17 412)
(16 626)
(18 263)
(18 939)
(19 548)
(18 742)
(20 066)
(20 336)
(20 543)
Depreciation & Amortization
0
(706)
0
0
0
(833)
0
0
0
(941)
0
0
0
(985)
0
0
0
(974)
0
0
0
(1 016)
0
0
0
(1 135)
0
0
0
(965)
0
0
0
(1 029)
0
0
0
(1 064)
0
0
0
Other Operating Expenses
657
649
727
757
688
798
762
811
853
0
962
939
952
0
823
812
818
0
952
969
1 012
1 051
1 089
1 056
1 051
983
3 402
3 446
1 258
1 263
1 182
1 157
949
1 034
1 164
1 246
1 244
1 258
1 276
1 339
1 440
Operating Income
8 599
N/A
8 960
+4%
9 177
+2%
9 218
+0%
9 308
+1%
9 833
+6%
9 937
+1%
10 020
+1%
10 313
+3%
9 064
-12%
9 597
+6%
9 714
+1%
10 144
+4%
9 469
-7%
11 402
+20%
11 838
+4%
12 182
+3%
10 873
-11%
11 143
+2%
11 109
0%
11 253
+1%
12 051
+7%
12 261
+2%
10 769
-12%
9 702
-10%
8 525
-12%
9 704
+14%
10 809
+11%
9 368
-13%
11 223
+20%
13 960
+24%
15 498
+11%
16 489
+6%
16 984
+3%
16 859
-1%
17 289
+3%
17 903
+4%
18 892
+6%
19 635
+4%
19 819
+1%
20 283
+2%
Pre-Tax Income
Interest Income Expense
188
382
430
426
549
397
460
599
657
563
545
3 235
2 910
(51)
2 927
142
321
599
8 168
8 068
8 047
213
198
(29)
(325)
(553)
(733)
(641)
(658)
(630)
(588)
(562)
(525)
(502)
(457)
(406)
(333)
(240)
(191)
(148)
(120)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
209
0
0
0
2 880
0
0
0
0
0
0
0
7 619
0
0
13
2 429
0
0
2 416
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
2
0
2
1
(1)
0
(1)
(1)
0
859
0
(1)
(1)
840
(1)
0
0
915
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Pre-Tax Income
8 789
N/A
9 342
+6%
9 609
+3%
9 645
+0%
9 856
+2%
10 230
+4%
10 396
+2%
10 618
+2%
10 970
+3%
10 694
-3%
10 142
-5%
12 948
+28%
13 053
+1%
13 138
+1%
14 328
+9%
11 980
-16%
12 503
+4%
12 387
-1%
19 311
+56%
19 177
-1%
19 300
+1%
19 883
+3%
12 460
-37%
10 740
-14%
9 390
-13%
10 401
+11%
8 971
-14%
10 168
+13%
11 126
+9%
10 594
-5%
13 372
+26%
14 935
+12%
15 963
+7%
16 481
+3%
16 401
0%
16 883
+3%
17 570
+4%
18 652
+6%
19 444
+4%
19 671
+1%
20 163
+3%
Net Income
Tax Provision
(1 602)
(1 671)
(1 740)
(1 791)
(1 793)
(1 895)
(1 936)
(1 954)
(2 057)
(1 922)
(1 821)
(2 519)
(2 520)
(2 564)
(2 750)
(2 118)
(2 171)
(2 740)
(4 159)
(4 203)
(4 296)
(3 873)
(2 312)
(2 035)
(1 807)
(2 751)
(2 576)
(2 732)
(2 895)
(2 103)
(2 676)
(2 988)
(3 167)
(3 227)
(3 204)
(3 322)
(3 522)
(3 755)
(3 917)
(3 861)
(3 989)
Income from Continuing Operations
7 187
7 671
7 869
7 853
8 062
8 335
8 459
8 664
8 913
8 772
8 320
10 429
10 533
10 575
11 579
9 862
10 332
9 647
15 152
14 974
15 004
16 009
10 148
8 705
7 583
7 649
6 396
7 435
8 231
8 490
10 696
11 947
12 796
13 254
13 197
13 561
14 048
14 897
15 527
15 810
16 174
Income to Minority Interest
(266)
(278)
(261)
(255)
(305)
(314)
(322)
(348)
(351)
(385)
(366)
(354)
(375)
(359)
(417)
(449)
(456)
(456)
(441)
(440)
(459)
(492)
(502)
(467)
(434)
(435)
(411)
(456)
(543)
(554)
(656)
(695)
(667)
(648)
(564)
(529)
(511)
(522)
(549)
(560)
(568)
Net Income (Common)
6 921
N/A
7 394
+7%
7 607
+3%
7 597
0%
7 756
+2%
8 021
+3%
8 137
+1%
8 315
+2%
8 562
+3%
8 386
-2%
7 954
-5%
10 076
+27%
10 159
+1%
10 216
+1%
11 162
+9%
9 414
-16%
9 876
+5%
9 191
-7%
14 712
+60%
14 534
-1%
14 545
+0%
15 517
+7%
9 646
-38%
8 239
-15%
7 149
-13%
7 214
+1%
5 985
-17%
6 979
+17%
7 688
+10%
7 936
+3%
10 040
+27%
11 252
+12%
12 129
+8%
12 606
+4%
12 633
+0%
13 032
+3%
13 537
+4%
14 375
+6%
14 979
+4%
15 250
+2%
15 606
+2%
EPS (Diluted)
0.44
N/A
0.48
+9%
0.49
+2%
0.49
N/A
0.5
+2%
0.52
+4%
0.53
+2%
0.54
+2%
0.56
+4%
0.54
-4%
0.52
-4%
0.65
+25%
0.66
+2%
0.66
N/A
0.72
+9%
0.61
-15%
0.63
+3%
0.59
-6%
0.94
+59%
0.93
-1%
0.93
N/A
0.99
+6%
0.61
-38%
0.52
-15%
0.45
-13%
0.45
N/A
0.38
-16%
0.44
+16%
0.48
+9%
0.5
+4%
0.63
+26%
0.71
+13%
0.76
+7%
0.79
+4%
0.79
N/A
0.82
+4%
0.85
+4%
0.9
+6%
0.94
+4%
0.96
+2%
0.98
+2%

See Also

Summary
BDMS intrinsic value, competitors valuation, and company profile.
DCF Valuation
BDMS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BDMS stock valuation using valuation multiples.
Wall Street Estimates
BDMS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BDMS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 211,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.